The pH-Pepsin Mechanism
Why a single pH shift disables protein digestion entirely
Pepsin's narrow operating window
Pepsin is the stomach's primary digestive protease — the enzyme responsible for breaking down the proline bonds in proteins, including those in casein (dairy) and gluten (wheat). It has a narrow operational window: pepsin requires a gastric pH of approximately 2.0 for optimal activity and becomes essentially inactive above pH 4.0.
When the founding conditions described on the Molecular Origins page have elevated gastric pH above this threshold — through reduced parietal cell hydrochloric acid (HCl) output, H. pylori infection, proton pump inhibitor (PPI) therapy, chronic sympathetic dominance, or combinations of these — pepsin cannot fulfill its digestive function regardless of how much protein the child eats.
Gastric pH and pepsin activity
Why proline bonds are the critical target
Casein and gluten proteins contain an unusually high density of proline residues. Proline's unique cyclic structure creates rigid, corkscrew-shaped peptide bonds that are highly resistant to the proteases operating further along the small intestine. Pepsin is the only enzyme that can effectively cleave these proline bonds under normal digestive conditions. When pepsin is deactivated by elevated pH, proline-bonded peptide fragments from casein and gluten survive digestion intact — there is no downstream enzyme capable of finishing the job pepsin left undone.
These intact fragments do not simply pass harmlessly through. Their rigid corkscrew structure serves a double function: it resists small intestinal proteases that would otherwise degrade them, and it allows the intact peptide to mechanically penetrate the intestinal mucosal wall — contributing to the intestinal permeability consistently documented in ASD populations. The peptide enters systemic circulation through the compromised barrier, biologically active and structurally intact.
This is why dietary elimination of casein and gluten can produce observable changes in some affected children — not because these foods are inherently toxic, but because when pepsin cannot do its job, these proteins specifically generate bioactive peptide fragments that drive downstream cascade mechanisms. The problem is the pH. The food is the substrate.
Hidden Malnutrition
Eating enough protein — and still being amino acid deficient
Three essential amino acids trapped in undigested protein
Three essential amino acids depend critically on pepsin-mediated proline bond cleavage for their release from dietary protein: phenylalanine, tyrosine, and tryptophan. These are classified as essential because the human body cannot synthesize them internally — they must be obtained entirely from dietary protein.
When pepsin is deactivated by elevated gut pH, the proline bonds that lock these amino acids inside casein and gluten proteins cannot be broken. The amino acids remain trapped inside undigested peptide fragments that pass through the gut and are excreted rather than absorbed. No amount of dietary protein corrects this — the problem is not the quantity of protein consumed but the pH environment that has disabled the enzyme required to release what that protein contains.
The result is hidden malnutrition: a child consuming an apparently complete diet who is biochemically deficient in three amino acids that the body cannot produce on its own and can no longer extract from food. Standard dietary assessment measures what is eaten — not what is absorbed. This deficiency does not show up on a food diary. It shows up on an amino acid panel.
What these three amino acids produce
- Phenylalanine → precursor to tyrosine and dopamine
- Tyrosine → dopamine → norepinephrine → epinephrine
- Tryptophan → serotonin → melatonin
- Tryptophan → NAD⁺ via kynurenine salvage pathway
- Dopamine signaling insufficiency
- Norepinephrine dysregulation
- Serotonin depletion
- Melatonin insufficiency — sleep disruption
- NAD⁺ substrate deficit
The double tryptophan depletion
Tryptophan occupies a uniquely critical position in the cascade because it faces depletion from two independent directions simultaneously.
From above — pepsin inactivation prevents tryptophan release from proline-bonded dietary protein, reducing the supply entering circulation. This is the mechanism described on this page.
From below — once the immune activation described in the next cascade steps establishes itself, the enzyme indoleamine 2,3-dioxygenase 1 (IDO1) continuously diverts whatever tryptophan does reach systemic circulation into the kynurenine pathway, depleting it before it can be converted to serotonin.
The result is that serotonin synthesis is simultaneously limited by impaired supply and active enzymatic diversion. This explains why serotonin depletion in immune-derived autism is so clinically consistent and so resistant to dietary correction alone — the problem is operating at two independent points in the supply chain at once.
The hidden malnutrition insight for parents: Standard dietary assessment measures what a child eats. It does not measure what a child absorbs. A child consuming adequate dietary protein while unable to cleave proline bonds will show normal dietary intake records and deficient amino acid panel results simultaneously. The deficiency is invisible to the usual assessment tools — which is why it is called hidden malnutrition.
Opioid Peptides and the Food Selectivity Loop
Why the body drives toward the very foods that deepen the problem
Casomorphin and gliadorphin — exorphins from incomplete digestion
The intact peptide fragments that accumulate when pepsin cannot cleave proline bonds are not nutritionally inert. Casomorphin — derived from incompletely digested casein — and gliadorphin — derived from incompletely digested gluten — belong to a class of compounds called exorphins: peptides originating outside the body that bind to opioid receptors.
Casomorphin and gliadorphin bind to mu-opioid receptors throughout the gut and brain, producing opioid-like effects including dulled pain perception, altered mood, and food-seeking behavior. These are not trace effects — the receptor binding is specific, documented, and drives measurable behavioral consequences.
Why the body seeks more of the problem food
Two drives arrive at the same behavioral output simultaneously, explaining the characteristic and often intense food selectivity of affected children as a convergent biological phenomenon — not a behavioral preference or sensory quirk.
Opioid reward signal: Casomorphin and gliadorphin bind mu-opioid receptors, producing biochemical reward from the foods that generate them — dairy and wheat. The body learns that these foods produce a neurochemical response it has come to depend on.
Amino acid deficiency detection: The body's homeostatic systems detect low circulating phenylalanine, tyrosine, and tryptophan and generate food-seeking signals directed toward protein-rich sources — which dairy and wheat correctly represent. The body is seeking the nutrients it is deficient in.
The trap: The digestive mechanism that should release those nutrients is the same mechanism that is generating the deficiency. Eating more dairy and wheat in response to both signals deepens the opioid peptide load and the amino acid deficit simultaneously. The food-seeking behavior is biologically rational — and biologically counterproductive.
The resistance to elimination: When families remove dairy and wheat, the opioid withdrawal effect from casomorphin and gliadorphin produces genuine behavioral distress — heightened agitation, disrupted sleep, increased rigidity — that is often misread as evidence that the diet is harmful. It is instead evidence that the opioid receptor dependency was real. The behavioral deterioration during a casein- and gluten-free transition is mechanistically identical to what occurs when someone dependent on opioid street drugs stops taking them: the receptor sites accustomed to stimulation go unstimulated, and the nervous system reacts accordingly. The distress is withdrawal — not dietary harm.
CCK Overactivation and Gut SST-28 Dysregulation
How persistent opioid receptor activation locks the digestive hormone cascade into a suppressed state
The CCK feedback mechanism — and why it breaks
Cholecystokinin exists in two functionally distinct receptor forms. CCK-A receptors are expressed in the gut wall and on vagal afferent nerve fibers — they govern satiety signaling, gallbladder contraction, pancreatic enzyme release, and the activation of gut somatostatin. CCK-B receptors are expressed in the brain, where CCK acts as a neurotransmitter modulating anxiety, pain, and reward circuits. The mechanism described here is specifically a CCK-A gut event — it is the peripheral digestive arm being chronically overstimulated, not the brain's CCK-B signaling.
Under normal conditions, the CCK-A feedback cycle is episodic and self-terminating: food intake raises CCK-A, which activates gut somatostatin, which suppresses further CCK-A release as digestion winds down. The cycle resets between meals. The key feature is that food — not a persistent molecular signal — is the driver, so the feedback loop has a natural off-switch.
Casomorphin and gliadorphin remove that natural off-switch. Because these opioid peptide fragments persist in the gut between meals — not cleared by the disabled pepsin mechanism that generated them — they provide a continuous CCK-A stimulus that food intake does not. The body reads this as a perpetual digestive demand and upregulates CCK synthesis accordingly. SST-28 is driven into tonic overexpression not because digestion is continuously happening, but because a molecular signal that normally accompanies digestion has become structurally permanent.
Tonic gut SST-28 overexpression — suppressing the entire digestive cascade
Chronic CCK-A overactivation drives gut SST-28 — the 28-amino-acid form of somatostatin produced by intestinal D-cells — into sustained overexpression. SST-28 is the primary inhibitory regulator of the digestive hormone cascade. Under normal conditions it provides episodic, self-limiting inhibition coordinated with the digestive cycle.
In immune-derived autism, SST-28 becomes tonically and globally overactive, suppressing the entire digestive hormone cascade continuously. The consequences compound each other:
- Gastric acid output falls — further elevating pH and further compounding pepsin inactivation. The mechanism that initiated the cascade is now perpetuated by the cascade itself.
- Secretin release fails — S-cells in the duodenum release secretin only when luminal acid drops the pH below 4.2. With gastric acid suppressed by overactive SST-28 and gut pH chronically elevated, that threshold is never reached. Secretin goes unreleased not because the S-cells are damaged, but because the pH signal that should trigger them never arrives.
- vasoactive intestinal peptide (VIP)-driven gut motility is reduced — contributing to slow transit, constipation, and irregular bowel function
- Motilin-stimulated peristalsis is impaired — the migrating motor complex that drives gut emptying between meals weakens
- Gastrin suppression reduces the parietal cell stimulation needed for acid recovery
Same gene, opposite dysfunction: In the gut, SST-28 is tonically overactive — suppressing the digestive hormone cascade. In the brain, SST-14 is being silenced — failing to coordinate the release of oxytocin, VIP, and secretin from the neuropeptide cascade. Same gene. Same precursor. Opposite dysfunction in two different compartments. The gut dysfunction is the initiating event; the brain dysfunction is the eventual convergent outcome.
Two Arms, One Trigger
The CCK/SST-28 arm and the CD26/adenosine arm — both initiated by opioid peptide accumulation, both converging independently on SST-14 silencing
The opioid peptides casomorphin and gliadorphin initiate not one but two mechanistically distinct downstream cascade pathways. They share the same upstream trigger — pepsin inactivation and opioid peptide accumulation — but produce entirely different biochemical consequences that converge independently on the same outcome: SST-14 interneuron silencing in the brain.
Opioid receptor activation → CCK-A overactivation → gut SST-28 tonic overexpression → digestive hormone cascade suppression. Described on this page.
Casomorphin and gliadorphin block the CD26 receptor → adenosine accumulation → methionine synthase rate-limiting → methylation cycle failure. Described on CD26, Adenosine & Methylation.
Both arms proceed in parallel from the same triggering event. Neither waits for the other. A child with elevated opioid peptide load is simultaneously accumulating gut SST-28 overactivation and adenosine-driven methylation failure — two distinct biochemical crises advancing concurrently toward the same convergent node.
This parallel structure is why single-target interventions characteristically produce partial improvement followed by plateau: addressing one arm does not arrest the other.
The full cascade from this point — lipopolysaccharide (LPS) translocation, IDO1 activation, nuclear factor kappa B (NF-κB) transcriptional suppression, and SST-14 interneuron silencing — is described on the Cascade Explained page. The CD26 arm is described in detail on CD26, Adenosine & Methylation.
Biomarkers for This Mechanism
Laboratory findings that identify pepsin failure, opioid peptide accumulation, and hidden malnutrition
The pepsin failure and opioid peptide mechanism is not detectable by standard dietary assessment. It requires specific laboratory investigation. The following findings, in combination, constitute a strong biomarker signal for this mechanism as the operative upstream driver.
These biomarkers do not replace clinical assessment. They direct it. A child presenting with amino acid deficiency, detectable urinary peptides, and elevated gut permeability markers has a measurable, mechanistically coherent upstream driver that informs a specific intervention sequence — not a collection of unrelated laboratory abnormalities. See the Testing Strategy and Test Reference pages for full guidance on ordering and interpreting these tests.